Norepinephrine in the brain is associated with aversion to financial loss
Norepinephrine in the brain is associated with aversion to financial loss
复制标题
DOI:
10.1038/mp.2012.7
复制
发表时间:
2013
影响因子:
11
通讯作者:
H. Takahashi;S. Fujie;Colin Camerer;R. Arakawa;H. Takano;F. Kodaka;H. Matsui;T. Ideno;S. Okubo;K. Takemura;M. Yamada;Y. Eguchi;T. Murai;Y. Okubo;M. Kato;H. Ito;T. Suhara
中科院分区:
文献类型:
--
作者:
H. Takahashi;S. Fujie;Colin Camerer;R. Arakawa;H. Takano;F. Kodaka;H. Matsui;T. Ideno;S. Okubo;K. Takemura;M. Yamada;Y. Eguchi;T. Murai;Y. Okubo;M. Kato;H. Ito;T. Suhara
Understanding the molecular mechanism of extreme or impaired decision-making observed in neuropsychiatric disorders, such as pathological gambling and attention-deficit hyperactivity disorder (ADHD), could contribute to better assessment and the development of novel pharmacological therapies for those disorders. Typically, most people show a disproportionate distaste for possible losses compared with equal-sized gains. This human in vivo molecular imaging study has demonstrated that individuals with lower thalamic norepinephrine transporters (NET) showed more exaggerated aversion to financial loss.Empirical and field studies suggest that losses have greater impact than equivalent gains. 1 For example, a typical person would only accept a two-outcome gamble in which $50 could be lost if the possible gain is $100, twice as large. This greater sensitivity to losses than to gains is called ‘loss aversion’and substantial individual differences in it have been observed in many behavioral studies. 1, 2 In psychiatric populations, pathological gambling showed diminished sensitivity to monetary loss itself and, more specifically, patients with ADHD and psychopaths showed reduced sensitivity to the magnitude of monetary